Home » Psychology news » Risk of serotonin syndrome in patients prescribed triptans for migraine, antidepressants

Risk of serotonin syndrome in patients prescribed triptans for migraine, antidepressants

February 26, 2018 by

The risk of serotonin syndrome in patients prescribed both triptans for migraine and antidepressants appears to be low, which may suggest an advisory from the US Food and Administration on that risk should be reconsidered.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>